These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
351 related items for PubMed ID: 22051503
1. Comparison between the automated Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 test version 2.0 assay and its version 1 and Nuclisens HIV-1 EasyQ version 2.0 assays when measuring diverse HIV-1 genotypes in China. Xu S, Song A, Nie J, Li X, Meng S, Zhang C, Wang Y. J Clin Virol; 2012 Jan; 53(1):33-7. PubMed ID: 22051503 [Abstract] [Full Text] [Related]
2. Performance of NucliSens HIV-1 EasyQ Version 2.0 compared with six commercially available quantitative nucleic acid assays for detection of HIV-1 in China. Xu S, Song A, Nie J, Li X, Wang Y. Mol Diagn Ther; 2010 Oct 01; 14(5):305-16. PubMed ID: 21053996 [Abstract] [Full Text] [Related]
3. Performance of the automated COBAS AmpliPrep/COBAS TaqMan HIV-1 test on a genetically diverse panel of specimens from China: comparison to the COBAS amplicor HIV-1 monitor test, v1.5. Xu S, Song A, Li X, Nie J, Zhang C, Wang Y. Intervirology; 2010 Oct 01; 53(4):221-8. PubMed ID: 20332651 [Abstract] [Full Text] [Related]
4. Evaluation of the NucliSens EasyQ v2.0 assay in comparison with the Roche Amplicor v1.5 and the Roche CAP/CTM HIV-1 Test v2.0 in quantification of C-clade HIV-1 in plasma. Muenchhoff M, Madurai S, Hempenstall AJ, Adland E, Carlqvist A, Moonsamy A, Jaggernath M, Mlotshwa B, Siboto E, Ndung'u T, Goulder PJ. PLoS One; 2014 Oct 01; 9(8):e103983. PubMed ID: 25157919 [Abstract] [Full Text] [Related]
11. High correlation between the Roche COBAS® AmpliPrep/COBAS® TaqMan® HIV-1, v2.0 and the Abbott m2000 RealTime HIV-1 assays for quantification of viral load in HIV-1 B and non-B subtypes. Karasi JC, Dziezuk F, Quennery L, Förster S, Reischl U, Colucci G, Schoener D, Seguin-Devaux C, Schmit JC. J Clin Virol; 2011 Nov 01; 52(3):181-6. PubMed ID: 21813320 [Abstract] [Full Text] [Related]
12. Performance evaluation of the new Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 test version 2.0 for quantification of human immunodeficiency virus type 1 RNA. Pas S, Rossen JW, Schoener D, Thamke D, Pettersson A, Babiel R, Schutten M. J Clin Microbiol; 2010 Apr 01; 48(4):1195-200. PubMed ID: 20164281 [Abstract] [Full Text] [Related]
14. Comparative evaluation of the COBAS AmpliPrep/COBAS TaqMan HIV type 1 test (CAP/CTM) and VERSANT HIV type 1 RNA 3.0 assay (bDNA) for quantifying HIV type 1 viral loads in China. Xu S, Song A, Nie J, Li X, Li J, Bao Z, Wang Y. AIDS Res Hum Retroviruses; 2008 Nov 01; 24(11):1365-73. PubMed ID: 18928395 [Abstract] [Full Text] [Related]
16. Comparative evaluation of the Cobas Amplicor HIV-1 Monitor Ultrasensitive Test, the new Cobas AmpliPrep/Cobas Amplicor HIV-1 Monitor Ultrasensitive Test and the Versant HIV RNA 3.0 assays for quantitation of HIV-1 RNA in plasma samples. Berger A, Scherzed L, Stürmer M, Preiser W, Doerr HW, Rabenau HF. J Clin Virol; 2005 May 01; 33(1):43-51. PubMed ID: 15797364 [Abstract] [Full Text] [Related]
17. Comparison of the rate and size of HIV-1 viral load blips with Roche COBAS TaqMan HIV-1 versions 1.0 and 2.0 and implications for patient management. Garrett NJ, Apea V, Nori A, Ushiro-Lumb I, Oliver AR, Baily G, Clark DA. J Clin Virol; 2012 Apr 01; 53(4):354-5. PubMed ID: 22261125 [Abstract] [Full Text] [Related]
18. Validation of dilution of plasma samples with phosphate buffered saline to eliminate the problem of small volumes associated with children infected with HIV-1 for viral load testing using Cobas AmpliPrep/COBAS TaqMan HIV-1 test, version 2.0 (CAP CTM HIV v2.0). Mine M, Nkoane T, Sebetso G, Sakyi B, Makhaola K, Gaolathe T. J Virol Methods; 2013 Dec 01; 194(1-2):217-21. PubMed ID: 24025342 [Abstract] [Full Text] [Related]